key: cord-0303751-pmk6zw8e
authors: Pena, M.; Ampuero, M.; Garces, C.; Gaggero, A.; Garcia, P.; Velasquez, M. S.; Luza, R.; Alvarez, P.; Paredes, F.; Acevedo, J.; Farfan, M. J.; Solari, S.; Soto-Rifo, R.; Valiente-Echeverria, y. F.
title: Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals
date: 2021-02-15
journal: nan
DOI: 10.1101/2021.02.12.21251643
sha: 1384443e73157b54c5c44ecbf36aec91a7950763
doc_id: 303751
cord_uid: pmk6zw8e

Screening, testing and contact tracing plays a pivotal role in the control of COVID-19 pandemic. To carry out this strategy it is necessary to increase the testing capacity. Here, we compared a SARS CoV-2 rapid antigen test (RAT) and RT-PCR in 842 asymptomatic individuals from Tarapaca, Chile. We report a sensibility of 69.86%, a specificity of 99.61%, PPV of 94.44% and NPP of 97.22% with Ct values (Ct > 27) that were significantly higher among individuals with false-negative RAT. These results support the fact that RAT might have a significant impact in the identification of asymptomatic carriers in areas that lack well-equipped laboratories to perform SARS-CoV-2 real -time RT-PCR diagnostics or the results take more than 24-48 hours, as well as zones with high traffic of individuals, such as border/customs, airports, interregional bus, train stations or in any mass testing campaign requiring rapid results.

Given the increase in cases of SARS-CoV-2 infections worldwide, there is a need for a reliable 44 rapid diagnostic test in addition to existing gold standard real-time RT-PCR. Rapid antigen tests 45 (RAT) for SARS-CoV-2 can be performed onsite in mass testing, are inexpensive compared to 46 real-time RT-PCR, do not require specific and expensive machinery and the results are available 47 within 15 minutes (1), which could serve to evaluate chains of infection and their interruption. A 48 meta-analysis recently revealed that the average sensitivity and specificity of the RAT for SARS- 49 CoV-2 was 56.2% and 99.5%, respectively (2). Up to date, most of these validations were 50 carried out in symptomatic individuals or samples previously collected (3-7). In contrast, onsite 51 test validation studies in asymptomatic individuals are limited to supporting the use of RAT in 52 mass testing and epidemiological surveillance (8-12).

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 13, 2021.

We evaluated the performance of the SARS-CoV-2 RAT (SD Biosensor, Inc. Republic of Korea, 56 Catalog number 9901-NCOV-01G; Lateral flow immunoassay, Readout: visual-coloured bands, 57 sensitivity of 96.52% and specificity of 99.68%) compared with the real-time RT-PCR for 58 SARS-CoV-2 detection among asymptomatic individuals at Iquique city, Tarapacá Region,

Chile. Samples were collected between January 14 th and January 17 th , 2021, where the 60 prevalence of SARS-CoV-2 infection was 11% in the region (13). Taking into consideration that 61 the expected prevalence of positives for COVID-19 in asymptomatic individuals can vary from 8 62 to 12% and establishing a sampling error of 1.5% and a type I error of 5%, then the minimum 63 size required was 864 ± 69,7. The sampling was carried out in seven testing sites corresponding 64 to i) workers (n=56; 6.7%), ii) sanitary residence (n=239; 28.4%), and iii) general public (n=547; 65 65%). Overall, 854 individuals were included (mean age: 36.67 years, SD: 16.48 years; male 66 n=51%; female n=41.6%; N/A n=7.4%). All participants completed a questionnaire and 67 provided information on demographic characteristics, current and past (14 days) symptoms, and 68 recent exposure to people with COVID-19 (Table 1) CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 13, 2021. ; Figure 1A ). Next, we performed the k-means clustering analysis to find clusters in an iterative 91 way using the Ct value of viral gene N (7). We identified three clusters: c1=16.87 (n=31, low Ct (Table 1) .

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 13, 2021. ; https://doi.org/10.1101/2021.02.12.21251643 doi: medRxiv preprint CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 13, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 13, 2021. ;

January 2021 

Coronavirus disease 2019 (COVID-19): interim guidance for antigen testing for SARS-CoV-2

point-of-care 164 antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection

Antigen Tests for COVID-19. Viruses

Comparative 169 evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium. Travel 170 Med Infect Dis

Comparison of the 172 SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit

Evaluation of a novel 175 antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples

Urgent need of rapid tests 178 for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2

CoV-2 infection by rapid antigen test in comparison with RT-PCR in a public setting

Evaluation of a SARS-CoV-184 2 rapid antigen test: potential to help reduce community spread?

Rethinking Covid-19 Test Sensitivity -A Strategy for 186 Containment. The New England journal of medicine

Limits and Opportunities of SARS-CoV-2 188

Antigen Rapid Tests: An Experienced-Based Perspective. Pathogens

Performance and 190 Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-throughput Drive-191 through Community Testing Site in Massachusetts

Reporte Diario Coronavirus -23 enero 2021

Clinical infectious diseases : an official publication of the Infectious Diseases 195 Society of America

Duration of 197 infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19